#investigates
Yale-Led Clinical Trial Investigates Anti-Inflammatory Drug Adalimumab to Prevent Parkinson’s Disease in High-Risk Patients
In a groundbreaking approach to neurodegenerative disease research, a team of Yale-led scientists has launched a major clinical...
Yale-Led Clinical Trial Investigates Anti-Inflammatory Drug Adalimumab to Prevent Parkinson’s Disease in At-Risk Patients
In a groundbreaking endeavor that bridges neurology, sleep medicine, and immunology, researchers at the Yale School of Medicine...
Yale-Led Clinical Trial Investigates Anti-Inflammatory Drug Adalimumab to Prevent Parkinson’s Disease in High-Risk Patients
A groundbreaking clinical trial led by researchers at the Yale School of Medicine has officially launched to investigate...
